128 related articles for article (PubMed ID: 10375593)
1. Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma.
Evertsson S; Bartik Z; Zhang H; Jansson A; Sun XF
Int J Oncol; 1999 Jul; 15(1):53-8. PubMed ID: 10375593
[TBL] [Abstract][Full Text] [Related]
2. The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma.
Zhang MS; Hu AH; Qiu H; Xiong HH; Chen Y
Med Oncol; 2012 Jun; 29(2):928-32. PubMed ID: 21380782
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2,p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Nordenskjöld B
Int J Cancer; 1996 Feb; 69(1):5-8. PubMed ID: 8600060
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
6. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic index and bcl-2 expression as prognostic factors in colorectal carcinoma.
Bendardaf R; Ristamäki R; Kujari H; Laine J; Lamlum H; Collan Y; Pyrhönen S
Oncology; 2003; 64(4):435-42. PubMed ID: 12759543
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis as a prognostic factor in colorectal carcinoma.
Sugamura K; Makino M; Kaibara N
Surg Today; 1998; 28(2):145-50. PubMed ID: 9525002
[TBL] [Abstract][Full Text] [Related]
9. Protein expression of NF-kappaB in human colorectal adenocarcinoma.
Evertsson S; Sun XF
Int J Mol Med; 2002 Nov; 10(5):547-50. PubMed ID: 12373289
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.
Conlin A; Smith G; Carey FA; Wolf CR; Steele RJ
Gut; 2005 Sep; 54(9):1283-6. PubMed ID: 15843421
[TBL] [Abstract][Full Text] [Related]
12. Incidence of apoptosis increases with age in colorectal cancer.
Tanaka K; Nagaoka S; Takemura T; Arai T; Sawabe M; Takubo K; Sugihara K; Kitagawa M; Hirokawa K
Exp Gerontol; 2002 Dec; 37(12):1469-79. PubMed ID: 12559416
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer.
Sheehan KM; O'Donovan DG; Fitzmaurice G; O'Grady A; O'Donoghue DP; Sheahan K; Byrne MF; Conroy RM; Kay EW; Murray FE
Eur J Gastroenterol Hepatol; 2003 Apr; 15(4):375-80. PubMed ID: 12655257
[TBL] [Abstract][Full Text] [Related]
16. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival.
Dix BR; Robbins P; Soong R; Jenner D; House AK; Iacopetta BJ
Int J Cancer; 1994 Dec; 59(6):747-51. PubMed ID: 7989112
[TBL] [Abstract][Full Text] [Related]
17. Assessment of biomarkers in paired primary and recurrent colorectal adenocarcinomas.
Seong J; Chung EJ; Kim H; Kim GE; Kim NK; Sohn SK; Min JS; Suh CO
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1167-73. PubMed ID: 10613309
[TBL] [Abstract][Full Text] [Related]
18. Detection of apoptotic cells in human colorectal cancer by two different in situ methods: antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) methods.
Watanabe I; Toyoda M; Okuda J; Tenjo T; Tanaka K; Yamamoto T; Kawasaki H; Sugiyama T; Kawarada Y; Tanigawa N
Jpn J Cancer Res; 1999 Feb; 90(2):188-93. PubMed ID: 10189889
[TBL] [Abstract][Full Text] [Related]
19. Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classifications for colorectal cancer.
Neoptolemos JP; Oates GD; Newbold KM; Robson AM; McConkey C; Powell J
Br J Surg; 1995 Feb; 82(2):184-7. PubMed ID: 7749683
[TBL] [Abstract][Full Text] [Related]
20. [Significance of apoptosis status and apoptosis-associated antigen expression in human colorectal adenocarcinoma sequence].
Li L; Yan L; Wei Y; Liu Z; Wang Z; Lei S; Huang G
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun; 30(2):185-7, 191. PubMed ID: 12212055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
